Dejan Radeski

Dejan Radeski is a Clinical Senior Lecturer at the University of Western Australia (UWA), affiliated with the UWA Medical School and the Department of Pathology & Laboratory Medicine. His primary role involves clinical and academic responsibilities in hematology and oncology. He is based in Perth, Australia, and contributes to research aligned with UN Sustainable Development Goals, focusing on improving healthcare outcomes.

His research interests center on lymphoma subtypes, particularly peripheral T-cell lymphomas, cutaneous lymphomas, and B-cell chronic lymphocytic leukemia. He employs techniques like fluorescence in situ hybridization (FISH) and investigates therapeutic interventions such as AFM13 and BV-CHEP. Additionally, he explores the phenogenomic aspects of post-transplant plasmablastic lymphomas, with a focus on Epstein-Barr Virus and related molecular pathways.

• Key contributions include a consensus practice statement on peripheral T-cell lymphoma diagnosis and management, developed with the Australasian Lymphoma Alliance.
• He leads a research project on imaging flow cytometry for multiple myeloma assessment, funded by the Haematology Society of Australia and New Zealand (2016).

His work emphasizes translational research, bridging clinical practice and laboratory findings to advance treatment strategies for hematological malignancies.